4 research outputs found
Trends of non-union and prescriptions for non-steroidal anti-inflammatory drugs in the United States, 1993β2012
<div><p><b>Background and purpose β</b> Surgical care and pain management for patients with fractures have evolved over the years. We wanted to ascertain if there were any changes in the incidence of non-unions and, if so, whether the use of non-steroidal anti-inflammatory drugs (NSAIDs), including COX-2 selective inhibitors, might have an effect.</p><p><b>Patients and methods β</b> We used the National Inpatient Sample (NIS) to estimate the annual number of patients hospitalized for surgical treatment of a non-union between 1993 and 2012, and calculated age-adjusted rates of non-union. We estimated the prevalence of prescriptions for NSAIDs from 1996 through 2012 using the Medical Expenditure Panel Survey (MEPS). The interrupted time-series analysis was used to relate quarterly rates of non-union to changes in prescriptions for NSAIDs between 1996 and 2009.</p><p><b>Results β</b> The annual estimate of non-unions in the USA declined 30% from 25,634 in 1993 to 17,815 in 2012 (p < 0.001). Specifically, the age-adjusted rate of non-unions decreased by 44% from 8.6 per 10<sup>5</sup> persons in 1996 to 4.8 per 10<sup>5</sup> persons in 2012 (p < 0.001). However, there was an 8% increase in the incidence rate of non-unions (p = 0.003) between 2000 and 2004, when certain COX-2 selective inhibitors were on the market and their prescriptions were prevalent at around 6% among those with fractures. A drop in non-union estimates from 22,321 in 2010 to 18,789 in 2011 (p = 0.04) also coincided with a marked decrease in prescriptions for NSAIDs in patients with fractures, from 22% to 14% (p = 0.02).</p><p><b>Interpretation β</b> Non-unions in the USA declined substantially between 1993 and 2012, but this was interrupted by changes in prescriptions for NSAIDs, with sustained increases between 2000 and 2004 followed by transient decreases in 2005 and 2011.</p></div
Subgroup Analysis of Compliant Use from the US Study Population of the Global Orthopedic Registry (GLORY).
<p>LMWH: low molecular weight heparin; CI, confidence interval; VTE: venous thromboembolism.</p><p>*LMWH vs. Warfarin.</p>β <p>Values are given as the number of patients with the percentage in parentheses.</p
Baseline Characteristics of the US Patients from the Global Orthopedic Registry (GLORY, Nβ=β3,755).
<p>ASA, American society of Anesthesiologists; LMWH, low molecular weight heparin.</p
Study cohort.
<p>Note that 84.7% of patients who received warfarin and 93.3% of those with LMWH also received elastic stockings and/or intermittent pneumatic compression devices. There were 30 patients of US patients who did not have record for prophylaxis, and 159 of them receiving mechanical prophylaxis only. GLORY: Global Orthopedic Registry. LMWH, low molecular weight heparin.</p